ST葫芦娃：获得药品注册证书

Group 1 - The company has received approval from the National Medical Products Administration for the drug registration certificates of Metformin and Empagliflozin Tablets (I) and Inhaled Compound Ipratropium Bromide Solution [1] - The total research and development expenses for Metformin and Empagliflozin Tablets (I) amount to 11.60 million yuan [1] - The total research and development expenses for Inhaled Compound Ipratropium Bromide Solution amount to 3.17 million yuan [1]